retatrutide triple agonist glp-1 gip glucagon phase 2 trial obesity Retatrutide, a GIP, and receptor agonist, for people with type diabetes: a Retatrutide: Triple-Agonist for Obesity and
Pay in 4 interest-free payments of $5.61 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
























